These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 26680725)

  • 1. Influence of Crystal Habit on the Dissolution of Simvastatin Single Crystals.
    Bukovec P; Meden A; Smrkolj M; Vrečer F
    Acta Chim Slov; 2015; 62(4):958-66. PubMed ID: 26680725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of crystal habit on the dissolution behaviour of simvastatin crystals and its relationship to crystallization solvent properties.
    Bukovec P; Benkic P; Smrkolj M; Vrecer F
    Pharmazie; 2016 May; 71(5):263-8. PubMed ID: 27348970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simvastatin-Nicotinamide Co-Crystals: Formation, Pharmaceutical Characterization and in vivo Profile.
    Khan FM; Ahmad M; Idrees HA
    Drug Des Devel Ther; 2020; 14():4303-4313. PubMed ID: 33116417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymorphism in Simvastatin: Twinning, Disorder, and Enantiotropic Phase Transitions.
    Simões RG; Bernardes CES; Joseph A; M Piedade MF; Kraus W; Emmerling F; Diogo HP; Minas da Piedade ME
    Mol Pharm; 2018 Nov; 15(11):5349-5360. PubMed ID: 30230340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Solubility enhancement of simvastatin: a review.
    Murtaza G
    Acta Pol Pharm; 2012; 69(4):581-90. PubMed ID: 22876598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A redispersible dry emulsion system with simvastatin prepared via fluid bed layering as a means of dissolution enhancement of a lipophilic drug.
    Pohlen M; Pirker L; Luštrik M; Dreu R
    Int J Pharm; 2018 Oct; 549(1-2):325-334. PubMed ID: 30075251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physicochemical and dissolution studies of simvastatin solid dispersions with Pluronic F127.
    Karolewicz B; Gajda M; Owczarek A; Pluta J; Górniak A
    Pharmazie; 2014 Aug; 69(8):589-94. PubMed ID: 25158569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dissolution kinetics of paracetamol single crystals.
    Prasad KV; Ristic RI; Sheen DB; Sherwood JN
    Int J Pharm; 2002 May; 238(1-2):29-41. PubMed ID: 11996808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of solvents in improvement of dissolution rate of drugs: crystal habit and crystal agglomeration.
    Maghsoodi M
    Adv Pharm Bull; 2015 Mar; 5(1):13-8. PubMed ID: 25789214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation and characterization of solid dispersion of simvastatin.
    Silva TD; Arantes VT; Resende JA; Speziali NL; de Oliveira RB; Vianna-Soares CD
    Drug Dev Ind Pharm; 2010 Nov; 36(11):1348-55. PubMed ID: 20545512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation and statistical optimization of alginate based stomach specific floating microcapsules of simvastatin.
    Premchandani TA; Barik BB
    Acta Pol Pharm; 2012; 69(4):751-61. PubMed ID: 22876619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation and characterization of simvastatin/DMβCD complex and its pharmacokinetics in rats.
    Gu F; Ning J; Fan H; Wu C; Wang Y
    Acta Pharm; 2018 Jun; 68(2):145-157. PubMed ID: 29702479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can crystal engineering be as beneficial as micronisation and overcome its pitfalls?: A case study with cilostazol.
    Sai Gouthami K; Kumar D; Thipparaboina R; Chavan RB; Shastri NR
    Int J Pharm; 2015 Aug; 491(1-2):26-34. PubMed ID: 26068197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cocrystal habit engineering to improve drug dissolution and alter derived powder properties.
    Serrano DR; O'Connell P; Paluch KJ; Walsh D; Healy AM
    J Pharm Pharmacol; 2016 May; 68(5):665-77. PubMed ID: 26408342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced dissolution rate of simvastatin using spherical crystallization technique.
    Varshosaz J; Tavakoli N; Salamat FA
    Pharm Dev Technol; 2011 Oct; 16(5):529-35. PubMed ID: 20684739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rational formulation development and in vitro assessment of SMEDDS for oral delivery of poorly water soluble drugs.
    Sprunk A; Strachan CJ; Graf A
    Eur J Pharm Sci; 2012 Aug; 46(5):508-15. PubMed ID: 22521277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crystal Habits of Itraconazole Microcrystals: Unusual Isomorphic Intergrowths Induced via Tuning Recrystallization Conditions.
    Mugheirbi NA; Tajber L
    Mol Pharm; 2015 Sep; 12(9):3468-78. PubMed ID: 26275018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of cyclodextrins as solubilizing agents for simvastatin: effect of hydroxypropyl-β-cyclodextrin on lactone/hydroxyacid aqueous equilibrium.
    Ungaro F; Giovino C; Catanzano O; Miro A; Mele A; Quaglia F; La Rotonda MI
    Int J Pharm; 2011 Feb; 404(1-2):49-56. PubMed ID: 21056648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic effect of polyethylene glycol and superdisintegrant on dissolution rate enhancement of simvastatin in pellet formulation.
    Afrasiabi Garekani H; Aftabi SF; Nia FF; Javidi M; Nokhodchi A; Sadeghi F
    Pharm Dev Technol; 2019 Jul; 24(6):720-728. PubMed ID: 30776937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A stable amorphous statin: solid-state NMR and dielectric studies on dynamic heterogeneity of simvastatin.
    Nunes TG; Viciosa MT; Correia NT; Danède F; Nunes RG; Diogo HP
    Mol Pharm; 2014 Mar; 11(3):727-37. PubMed ID: 24499472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.